Truist Securities Maintains Buy on Merck & Co, Raises Price Target to $143
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Robyn Karnauskas maintains a Buy rating on Merck & Co (NYSE:MRK) and raises the price target from $142 to $143.

April 26, 2024 | 3:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Buy rating on Merck & Co and raises the price target to $143.
The upgrade in price target by Truist Securities reflects a positive outlook on Merck & Co's stock, likely due to strong company fundamentals or expected performance. This can lead to increased investor confidence and potential short-term price appreciation.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100